BRIEF-GSK CEO says U.S. uptake of Anoro more rapid than Breo

July 23 (Reuters) - GlaxoSmithKline Plc analyst call: * CEO says U.S. pickup of new lung drug Anoro much more rapid than Breo * CFO says no change to dividend policy
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.